Photon- and proton-based radiation therapy conferred comparable health-related quality of life for people with breast cancer, ...

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report ...

Leo Cancer Care announced that it has placed orders for TibaRay's advanced linear accelerators (linacs), which will be ...

BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not ...

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report equally strong health-related quality of life with either treatment.

Leo Cancer Care is using ASTRO 2025 to launch Grace™, the company's upright photon therapy system. Grace is named after ...

Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and RTOG Foundation RadComp study indicated that both photon and proton radiation treatment options ...

The company makes upright radiation therapy systems using a fixed beam with slow patient rotation instead of a gantry.

The Grace radiotherapy system delivers conventional X-ray radiation therapy to patients in the upright position ...